Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bosone

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Neuro-Oncology|January 5, 2000
The prognostic role of vessel productive changes and vessel density in oligodendrogliomaD Schiffer, I Bosone, A Dutto, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|October 23, 2001
Cyclin D1 expression in normal oligodendroglia and microglia cells: its use in the differential diagnosis of oligodendrogliomasI Bosone, P Cavalla, L Chiadò-Piat, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 17, 1997
Prognostic factors in oligodendrogliomaD Schiffer, A Dutto, P Cavalla, et al.
Journal of Neuro-Oncology|January 5, 2002
CDKN2A/p16 in ependymomasS Bortolotto, L Chiadò-Piat, P Cavalla, et al.
International Journal of Cancer|November 4, 2000
CDKN2A/p16 inactivation in the prognosis of oligodendrogliomasS Bortolotto, L Chiadò-Piat, P Cavalla, et al.
Neuropediatrics|June 21, 2002
Alpha-sarcoglycan deficiency featuring exercise intolerance and myoglobinuriaT Mongini, C Doriguzzi, I Bosone, et al.
Neuroscience Letters|May 13, 1999
Cell-cycle inhibitor p27/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumorsD Schiffer, S Bortolotto, I Bosone, et al.
Clinical Neuropathology|October 12, 2001
Late onset and very mild course of Xp21 Becker type muscular dystrophyI Bosone, S Bortolotto, T Mongini, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Neuro-Oncology|January 5, 2000
The prognostic role of vessel productive changes and vessel density in oligodendrogliomaD Schiffer, I Bosone, A Dutto, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|October 23, 2001
Cyclin D1 expression in normal oligodendroglia and microglia cells: its use in the differential diagnosis of oligodendrogliomasI Bosone, P Cavalla, L Chiadò-Piat, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|December 17, 1997
Prognostic factors in oligodendrogliomaD Schiffer, A Dutto, P Cavalla, et al.
Journal of Neuro-Oncology|January 5, 2002
CDKN2A/p16 in ependymomasS Bortolotto, L Chiadò-Piat, P Cavalla, et al.
International Journal of Cancer|November 4, 2000
CDKN2A/p16 inactivation in the prognosis of oligodendrogliomasS Bortolotto, L Chiadò-Piat, P Cavalla, et al.
Neuropediatrics|June 21, 2002
Alpha-sarcoglycan deficiency featuring exercise intolerance and myoglobinuriaT Mongini, C Doriguzzi, I Bosone, et al.
Neuroscience Letters|May 13, 1999
Cell-cycle inhibitor p27/Kip-1 expression in non-astrocytic and non-oligodendrocytic human nervous system tumorsD Schiffer, S Bortolotto, I Bosone, et al.
Clinical Neuropathology|October 12, 2001
Late onset and very mild course of Xp21 Becker type muscular dystrophyI Bosone, S Bortolotto, T Mongini, et al.
Pageof 1